Corporate Banner
Satellite Banner
Technology Networks Header
Friday, July 25, 2014
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
Schizophrenia’s Genetic Skyline Rising
Suspect common variants soar from 30 to 108 - NIH-funded study.
Transplanting Gene into Injured Hearts Creates Biological Pacemakers
Researchers develop first minimally invasive gene therapy procedure to treat heart rhythm disorders by transforming ordinary heart muscle cells into specialized rhythm-keeping cells, potentially eliminating future need for electronic pacemakers.
Common Gene Variants Account for Most Genetic Risk for Autism
Roles of heritability, mutations, environment estimated - NIH-funded study.
Illumina's HiSeq X Ten Sequencing Technology for Population Studies
Next-generation sequencing technologies to be implemented at new High-Throughput Genomics Center for the MENA region.
Bowel Cancer Breakthrough May Benefit Thousands of Patients
Researchers at Queen’s University have discovered how two genes cause bowel cancer cells to become resistant to treatments used against the disease.
NIH Scientists Identify Gene Linked to Fatal Inflammatory Disease in Children
Repurposed drugs may offer first potential therapy.
Study Finds Low Oxygen Environment Helps Tumors Silence Critical Genes
The study led by Yale Cancer Center may provide clues to how some aggressive cancers turn off, or silence, genes critical to suppressing tumors.
Researchers Use ‘Big Data’ Approach to Map the Relationships Between Human and Animal Diseases
EID2 database used to prevent and tackle disease outbreaks around the globe.
Researchers Uncover New Cancer Cell Vulnerability
The research showed that telomerase-expressing cells depend upon a gene named p21 for their survival.
Self-assembling Nanoparticle Could Improve MRI Scanning for Cancer Diagnosis
Scientists have designed the nanoparticle that targets tumours, to help doctors diagnose cancer earlier.
Scroll Up
Scroll Down
Return
Genomic to the Epigenomic Era: Steps Towards Biomarker Discovery
Mohammad Hoque, Assistant Professor, Johns Hopkins University, speaking at European Biomarkers Summit 2009
Date Posted: Sunday, August 01, 2010
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



Potential New 'Twist' in Breast Cancer Detection
Mouse studies reveal new and better picture of stem cells that may fuel some breast cancers.
Monday, December 07, 2009
Johns Hopkins Researchers Develop Human Stem Cell Line Containing Sickle Cell Anemia Mutation
Researchers establish a human cell-based system for studying the disease by reprogramming somatic cells to an embryonic stem cell like state.
Tuesday, June 03, 2008
Johns Hopkins Researcher Leads International Effort to Create “Proteinpedia”
A Johns Hopkins researcher has led the effort to compile to date the largest free resource of experimental information about human proteins.
Thursday, February 07, 2008
RNA Shown to Silence Cancer Suppressor Gene
Discovery sheds light on epigenetic mechanisms in tumor development in plants and animals.
Tuesday, January 15, 2008
Cellular Pump Sabotages Cancer Drug Studies that use Glow Chemical
Scientists discover that a widely used means of illuminating cancer cells could undermine studies of the potential value of experimental anti-cancer drugs.
Thursday, January 03, 2008
More Functional DNA in Genome than Previously Thought
Hopkins researchers report that non-coding DNA, that contributes to inherited diseases like Parkinson’s or mental disorders, may be more abundant than we realize.
Thursday, December 20, 2007
Omicia and Johns Hopkins Receive Small Business Technology Transfer Grant from NIH
Omicia recieves a $187,700 grant from NIH to support a collaboration with Johns Hopkins University to identify genetic causes of cardiovascular disease.
Friday, August 17, 2007
Key to Lung Cancer Chemo Resistance Revealed
Products made by a gene called NRF2 normally protect cells from environmental pollutants.
Tuesday, October 17, 2006
 
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv